Healthcare provider profile · identity verified

Erik Rueckert, DO

Internal Medicine · ALBANY, OR · NPI 1295128619

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	729	201
Levothyroxine Sodium	Levothyroxine Sodium	564	139
Lisinopril	Lisinopril	417	103
Amlodipine Besylate	Amlodipine Besylate	396	105
Losartan Potassium	Losartan Potassium	378	108
Metoprolol Succinate	Metoprolol Succinate	300	84
Omeprazole	Omeprazole	273	74
Gabapentin	Gabapentin	267	67
Hydrochlorothiazide	Hydrochlorothiazide	235	60
Rosuvastatin Calcium	Rosuvastatin Calcium	217	60
Trazodone Hcl	Trazodone Hcl	211	55
Pantoprazole Sodium	Pantoprazole Sodium	202	48
Metformin Hcl	Metformin Hcl	190	50
Furosemide	Furosemide	182	47
Fluoxetine Hcl	Fluoxetine Hcl	167	37
Albuterol Sulfate Hfa	Albuterol Sulfate	162	59
Duloxetine Hcl	Duloxetine Hcl	141	38
Escitalopram Oxalate	Escitalopram Oxalate	137	29
Potassium Chloride	Potassium Chloride	137	43
Tamsulosin Hcl	Tamsulosin Hcl	131	38
Sertraline Hcl	Sertraline Hcl	129	33
Eliquis	Apixaban	124	25
Jardiance	Empagliflozin	119	35
Warfarin Sodium	Warfarin Sodium	105	29
Donepezil Hcl	Donepezil Hcl	100	22
Bupropion Xl	Bupropion Hcl	94	25
Trulicity	Dulaglutide	91	13
Metformin Hcl Er	Metformin Hcl	89	27
Ozempic	Semaglutide	87	20
Clopidogrel	Clopidogrel Bisulfate	83	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	20
Allopurinol	Allopurinol	80	22
Citalopram Hbr	Citalopram Hydrobromide	77	21
Alendronate Sodium	Alendronate Sodium	76	23
Simvastatin	Simvastatin	75	24
Ondansetron Odt	Ondansetron	67	31
Pregabalin	Pregabalin	67	15
Carvedilol	Carvedilol	64	20
Glipizide	Glipizide	60	18
Glimepiride	Glimepiride	55	13
Atenolol	Atenolol	52	12
Ezetimibe	Ezetimibe	48	17
Meloxicam	Meloxicam	47	19
Famotidine	Famotidine	45	12
Chlorthalidone	Chlorthalidone	42	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	11
Metoprolol Tartrate	Metoprolol Tartrate	42	14
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	15
Lamotrigine	Lamotrigine	40	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	40	suppressed
Spironolactone	Spironolactone	40	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	12
Cephalexin	Cephalexin	38	19
Baclofen	Baclofen	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	35	suppressed
Ipratropium Bromide	Ipratropium Bromide	35	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Nystatin	Nystatin	34	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Prednisone	Prednisone	33	14
Triamcinolone Acetonide	Triamcinolone Acetonide	33	21
Spiriva Respimat	Tiotropium Bromide	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Divalproex Sodium Er	Divalproex Sodium	29	suppressed
Promethazine Hcl	Promethazine Hcl	29	suppressed
Doxepin Hcl	Doxepin Hcl	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	24
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Azithromycin	Azithromycin	22	20
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Finasteride	Finasteride	21	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Risperidone	Risperidone	21	suppressed
Estradiol	Estradiol	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	16
Valacyclovir	Valacyclovir Hcl	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Valsartan	Valsartan	19	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	11
Acyclovir	Acyclovir	17	suppressed
Bydureon Bcise	Exenatide Microspheres	17	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	15
Aripiprazole	Aripiprazole	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	15
Phenobarbital	Phenobarbital	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	11
Lovastatin	Lovastatin	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Lactulose	Lactulose	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Topiramate	Topiramate	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error